Literature DB >> 10591418

Adverse events in intensively treated children and adolescents with type 1 diabetes.

S Nordfeldt1, J Ludvigsson.   

Abstract

The main objective of this study was to examine the relation between adverse events and degree of metabolic control and multiple-dose treatment. A total of 139 children, aged between 1 and 18 y, prospectively registered severe hypoglycaemia with or without unconsciousness, as well as hospitalized ketoacidosis, during 1994-95. Treatment from onset was multiple-dose insulin (> 95% > or = 4 doses) combined with intense training and psychosocial support. Median HbA1c was 6.9% (ref. 3.6-5.4%). The incidence of severe hypoglycaemia with unconsciousness was 0.17 events per patient-year, having decreased from the 1970s to the 1990s, parallel to a change from 1-2 to > or = 4 doses per day. There was no correlation or association to the year mean HbA1c for severe hypoglycaemia. Severe hypoglycaemic episodes in 1995 correlated to severe hypoglycaemic episodes in 1994 (r=0.38; p<0.0001). Severe hypoglycaemia with unconsciousness increased during the spring season, and according to case records the assumed causes were mainly mistakes with insulin, food and exercise. Ketoacidosis was rare: 0.015 episodes per patient-year. We conclude that multiple-dose insulin therapy from the very onset of diabetes, combined with adequate self-control, active problem-based training and psycho-social support, may limit severe hypoglycaemia and ketoacidosis. Strategies aimed at minimizing severe hypoglycaemia without compromising metabolic control need to be evaluated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10591418     DOI: 10.1080/080352599750030275

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  7 in total

Review 1.  Infant and toddler diabetes.

Authors:  Declan Cody
Journal:  Arch Dis Child       Date:  2007-08       Impact factor: 3.791

2.  Prevention of severe hypoglycaemia in type I diabetes: a randomised controlled population study.

Authors:  S Nordfeldt; C Johansson; E Carlsson; J-A Hammersjö
Journal:  Arch Dis Child       Date:  2003-03       Impact factor: 3.791

3.  Patient and parent views on a Web 2.0 Diabetes Portal--the management tool, the generator, and the gatekeeper: qualitative study.

Authors:  Sam Nordfeldt; Lena Hanberger; Carina Berterö
Journal:  J Med Internet Res       Date:  2010-05-28       Impact factor: 5.428

4.  Basal insulin supplementation in Type 1 diabetic children: a long-term comparative observational study between continuous subcutaneous insulin infusion and glargine insulin.

Authors:  R Schiaffini; P I Patera; C Bizzarri; P Ciampalini; M Cappa
Journal:  J Endocrinol Invest       Date:  2007 Jul-Aug       Impact factor: 4.256

5.  Treatment-Induced Neuropathy in Diabetes (TIND)-Developing a Disease Model in Type 1 Diabetic Rats.

Authors:  Petra Baum; Severin Koj; Nora Klöting; Matthias Blüher; Joseph Classen; Sabine Paeschke; Martin Gericke; Klaus V Toyka; Marcin Nowicki; Joanna Kosacka
Journal:  Int J Mol Sci       Date:  2021-02-04       Impact factor: 5.923

6.  Use of a web 2.0 portal to improve education and communication in young patients with families: randomized controlled trial.

Authors:  Lena Hanberger; Johnny Ludvigsson; Sam Nordfeldt
Journal:  J Med Internet Res       Date:  2013-08-23       Impact factor: 5.428

7.  Health professionals' attitudes towards using a Web 2.0 portal for child and adolescent diabetes care: qualitative study.

Authors:  Cecilia Nordqvist; Lena Hanberger; Toomas Timpka; Sam Nordfeldt
Journal:  J Med Internet Res       Date:  2009-04-06       Impact factor: 5.428

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.